Lyell Immunopharma, Inc. (LYEL) SEC Filings & Financial Intelligence
Lyell Immunopharma, Inc. (LYEL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LYEL
CIK: 1806952
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerRichard Shunn
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-05 | 2026-11-04 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-001014 | View SEC Doc Filr Page |
| 4 | 2026-11-05 | 2026-11-04 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-001013 | View SEC Doc Filr Page |
| 10-Q | 2026-11-04 | 2026-09-30 | 10-Q | 0001628280-26-070171 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0001628280-26-070161 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-03 | 8-K | 0001193125-26-446317 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0002150331-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-10 | 4 Filing | 0001959742-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-10 | 4 Filing | 0002150331-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-09-10 | 2026-08-31 | 3 Filing | 0002150331-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | 8-K | 0001193125-26-387890 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | 4 Filing | 0001327111-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | 4 Filing | 0001866154-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | 4 Filing | 0001907345-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097073 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | 4 Filing | 0002095702-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | 4 Filing | 0001907345-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | 4 Filing | 0001866154-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-10 | 4 Filing | 0001327111-26-000004 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-054367 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-054330 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-27 | FORM 4 | 0001140361-26-029817 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-27 | FORM 4 | 0001140361-26-029791 | View SEC Doc Filr Page |
| EFFECT | 2026-07-21 | — | EFFECT Filing | 9999999995-26-002375 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-17 | FORM 4 | 0001140361-26-028955 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001140361-26-028846 | View SEC Doc Filr Page |